Predicting high vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus bloodstream infections
about
Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients.Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysisCharacteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer centerDerivation and validation of clinical prediction rules for reduced vancomycin susceptibility in Staphylococcus aureus bacteraemia.The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): implications for therapy.Prevention and management of central line-associated bloodstream infections in hospital practice.Vancomycin therapeutics and monitoring: a contemporary approach.Vancomycin: the tale of the vanquisher and the pyrrhic victory.Bacteriophage-driven inhibition of biofilm formation in Staphylococcus strains from patients attending a Romanian reference center for infectious diseases.Is vancomycin MIC "creep" method dependent? Analysis of methicillin-resistant Staphylococcus aureus susceptibility trends in blood isolates from North East Scotland from 2006 to 2010.Evaluation of vancomycin susceptibility testing for methicillin-resistant Staphylococcus aureus: comparison of Etest and three automated testing methods.Effects of storage on vancomycin and daptomycin MIC in susceptible blood isolates of methicillin-resistant Staphylococcus aureus.Predicting methicillin resistance among community-onset Staphylococcus aureus bacteremia patients with prior healthcare-associated exposure.
P2860
Q35827804-ADBFAC41-674D-4C13-8AF0-4FE5F4BD67B4Q36078305-41DE76F4-2A44-4F11-B866-3DDC2FED85C5Q36349620-BAB1506C-E3E1-47B0-AEEC-2685F2A35305Q36456630-A8264E58-36D7-42F8-8AFC-51E6C5B1AAA2Q37981103-272AEAE8-A46C-42CF-982D-4B3948B0A456Q37982066-75BA342C-09B2-43DA-9D70-E1D96836BC58Q37992486-E2566C5F-0A1B-40B6-A561-E9439C7ED7B8Q38062923-C7BA3C04-BEA0-40AE-BC2B-36B8D4841CDEQ38542797-3DB5DF92-EF21-4D6E-A4A2-2B48DFAAA957Q40577373-B60F6365-9E92-48B9-9594-5D659A72A9A4Q40600332-F52F586E-F432-421D-AC92-027755929568Q41429045-4BD18C2E-47D7-4F39-8C1F-9C3E539059D8Q42270981-C1FAC445-4771-44C8-A917-374721C86CA4Q47739410-6A330DCD-4775-413A-9DAE-E9A35068DE4F
P2860
Predicting high vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus bloodstream infections
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Predicting high vancomycin min ...... aureus bloodstream infections
@ast
Predicting high vancomycin min ...... aureus bloodstream infections
@en
Predicting high vancomycin min ...... aureus bloodstream infections
@nl
type
label
Predicting high vancomycin min ...... aureus bloodstream infections
@ast
Predicting high vancomycin min ...... aureus bloodstream infections
@en
Predicting high vancomycin min ...... aureus bloodstream infections
@nl
prefLabel
Predicting high vancomycin min ...... aureus bloodstream infections
@ast
Predicting high vancomycin min ...... aureus bloodstream infections
@en
Predicting high vancomycin min ...... aureus bloodstream infections
@nl
P2093
P2860
P356
P1476
Predicting high vancomycin min ...... aureus bloodstream infections
@en
P2093
Andrew S Lubin
Pralhad Bide
Robin Ruthazer
Yoav Golan
P2860
P304
P356
10.1093/CID/CIR118
P407
P577
2011-04-01T00:00:00Z